Big Pharma targeting smaller companies, with megadeals now out of favor – Indianapolis Business Journal

Indianapolis-based Eli Lilly and Co. and Switzerland-based Novartis were the most active acquirers in the past 12 months, with seven and six deals respectively, according to data compiled by Bloomberg.

Related Keywords

Wouter Joustra , Versanis Bio , Johnson , Aiolos Bio Inc , Ambrx Biopharma Inc , Inhibrx Inc , Sigilon Therapeutics Inc , Bloomberg , Eli Lilly , Novartis , Ambrx Biopharma , Aiolos Bio , Switzerland Based Novartis , Point Biopharma Global , Sigilon Therapeutics ,